Medical News Today

Anoro Ellipta

Improvement in lung function was measured using FEV1 (forced expiratory volume in one second). FEV1 is a measurement of how much air you can force out of your lungs in one second. Higher FEV1 values ...
Yahoo UK & Ireland

GSK Presents Post-Hoc Analysis of Anoro(R) Ellipta(R) Data Assessing Markers of COPD Deterioration Compared to Tiotropium or Placebo Using a Novel Composite Endpoint

Anoro Ellipta should be used with caution in patients with urinary retention, especially in patients with prostatic hyperplasia or bladder neck obstruction. Instruct patients to contact a physician ...
McKnight's Long-Term Care News

FDA approves Anoro Ellipta

The U.S. Food and Drug Administration have approved GlaxoSmithKline’s Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive ...
BioWorld

Anoro Ellipta Briefing Docs Promising Ahead of PADAC Meeting

BioWorld - Tuesday, November 21, 2023 See today's BioWorld Home » Anoro Ellipta Briefing Docs Promising Ahead of PADAC Meeting Subscribe to BioWorld™ news services See subscription options To read the ...
The Financial

GSK presents post-hoc analysis of Anoro Ellipta data assessing markers of COPD deterioration compared to tiotropium or placebo using a novel composite endpoint

The FINANCIAL — GlaxoSmithKline plc (GSK) and Theravance, Inc. on September 27 announced data presented by GSK at the European Respiratory Society (ERS) International Congress (poster PA1001), from an ...